GlassScriptPhysician profile
Gavin Scott
NPI 1972363877
$3,584.87
in general payments reported to CMS, 2019-2025
9 companies · $3,256 in 2025
The $3,256 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $329 · 2025: $3,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,263 · Grant: $1,000 · Education: $321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,263.38 |
| Grant | $1,000.00 |
| Education | $321.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,477.61 | 2024-2025 | Arcos, Avenir, G7 |
| Smith+Nephew, INC. | $505.76 | 2024-2025 | Bone Anchors With Arthroscopic Delivery System, Footprint, Evos |
| Depuy Synthes Sales INC. | $420.40 | 2025 | Lcp, Va-Lcp, Tfn-Advance |
| Stryker Corporation | $362.86 | 2025 | Triathlon, Gamma, Mako |
| Medical Device Business Services, INC. | $321.49 | 2025 | Actis |
| Legacy Ortho LLC | $254.49 | 2024-2025 | |
| Si-Bone, INC. | $159.93 | 2025 | |
| Sanara Medtech INC. | $62.65 | 2025 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $19.68 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gavin Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.